Micardis HCT 12.5 mg/1 (Telmisartan and Hydrochlorothiazide TABLET) 12.5 mg/1

Micardis HCT 12.5 mg/1 combines telmisartan and hydrochlorothiazide for blood pressure management. This oral tablet helps regulate hypertension with a dual-action formula.

Strength

12.5 mg/1

Pack Size

3 BLISTER PACK in 1 CARTON (0597-0043-37) / 10 TABLET in 1 BLISTER PACK

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Micardis HCT 12.5 mg/1 is primarily used for managing high blood pressure. The combination of telmisartan, an angiotensin II receptor blocker, and hydrochlorothiazide, a diuretic, works to lower blood pressure by relaxing blood vessels and reducing fluid retention. This medication is often prescribed for individuals who require dual therapy to achieve optimal blood pressure control.

Side Effects

Common effects of Micardis HCT 12.5 mg/1 may include dizziness, fatigue, and mild nausea. Some users might experience dehydration or electrolyte imbalances due to the diuretic component. It's important to stay hydrated and monitor for any unusual symptoms while taking this medication.

Precautions & Warnings

Micardis HCT 12.5 mg/1 should be handled with care, especially for those with kidney or liver issues. Regular monitoring of blood pressure and electrolyte levels is recommended. Avoid sudden changes in dosage without consulting a healthcare provider.

Avoid Interactions

Micardis HCT 12.5 mg/1 may interact with other blood pressure medications, NSAIDs, and certain supplements. Alcohol consumption should be limited, as it can enhance the effects of the diuretic component. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Micardis HCT 12.5 mg/1 is used to manage high blood pressure by combining telmisartan and hydrochlorothiazide.

Store Micardis HCT 12.5 mg/1 at room temperature, away from moisture and heat.

Yes, dizziness is a common effect of Micardis HCT 12.5 mg/1, especially when starting the medication.

Long-term use of Micardis HCT 12.5 mg/1 should be monitored by a healthcare provider to ensure safety and effectiveness.

If you miss a dose, take it as soon as you remember. Skip the missed dose if it's almost time for your next dose.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.